Browse > Article

Change of Ratio of Onchungeum Composition Induces Different G1 Arrest Mechanisms in Hep3B Cells  

Goo, In-Moo (Department of Physiology, College of Oriental Medicine, Dongguk University)
Kim, Gil-When (Department of Physiology, College of Oriental Medicine, Dongguk University)
Shin, Heung-Mook (Department of Physiology, College of Oriental Medicine, Dongguk University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.22, no.5, 2008 , pp. 1250-1255 More about this Journal
Abstract
Onchungeum(OCE), a herbal formula, has been used for treatment of anemia, discharging blood and skin diseases. In the previous study, we investigated the anti-cancer effect of OCE by G1 arrest of the cell cycle in human hepatocarcinoma cells, Hep3B cells. In this study, it was examined that the difference of anti-proliferative mechanisms by change in the ratio of OCE composition (OCE I) in Hep3B cells. Treatment of OCE I exhibited a relatively strong anti-proliferative activity and caused various morphological changes such as membrane shrinkage and cell floating. In addition, OCE-I arrests the cell cycle at G1 phase, which was associated with the down-regulation of cyclin D1 and Cdk6 expressions. The G1 arrest was also associated with the induction of Cdk inhibitors p27 and p21. Moreover, both p21 and p27 were detected by immunoprecipitation with anti-Cdk4 and anti-Cdk2 antibodies in OCE I-treated cells but in case of OCE, p21 did not make any complexes with Cdk4 and Cdk2. These results suggest that the change in the ratio of OCE composition might induce different mechanisms in anti-cancer efficacy of OCE, which may confer characteristic principles in oriental medical formula.
Keywords
OCE I; Hep3B cells; G1 arrest; p21; p27; characteristic principles in oriental medical formula;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 龔廷賢. 萬病回春. 北京, 人民衛生出版社, p 338, 1995
2 許浚. 東醫寶鑑. 서울, 동의보감출판사, p 307, 314, 2005
3 구인모, 신흥묵. 溫淸飮이 인체 간암세포의 세포주기에 미치는 영향. 동의생리병리학회지 22(4):821-828, 2008   과학기술학회마을
4 Elledge, S.J., Harper, J.W. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6: 847-852, 1994   DOI   ScienceOn
5 Warbrick, E. The puzzle of PCNA's many partners. Bioessays 22: 997-1006, 2000   DOI   ScienceOn
6 Weinberg, R.A. The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995   DOI   ScienceOn
7 朴南錯. 漢方治療大全. 서울, 南山堂, p 444, 1989
8 Zeng, Y.X., El-Deiry, W.S. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12: 1557-1564, 1996
9 Harris, M., Gibbs, P., Cebon, J., Jones, R., Sewell, R., Schelleman, T., Angus, P. Hepatocellular carcinoma and chemoembolization. Intern Med J. 31(9):517-522, 2001   DOI   ScienceOn
10 Dbouk, N., McGuire, B.M. Hepatic encephalopathy: a review of its pathophysiology and treatment. Curr Treat Options Gastroenterol. 9: 464-474, 2006   DOI   ScienceOn
11 Fotedar, R., Bendjennat, M., Fotedar, A. Role of p21WAF1 in the cellular response to UV. Cell Cycle 3: 134-137, 2004
12 Taylor, W.R., Stark, G.R. Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815, 2001   DOI   ScienceOn
13 이헌제, 성유진, 김상대, 문국진, 김종봉, 김길훤, 신흥묵. 半夏白朮天麻湯의 조성에 따른 혈관이완활성과 기전. 동의생리병리학회지 19(5):1311-1316, 2005
14 Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993   DOI   ScienceOn
15 Boulaire, J. Fotedar, A. Fotedar, R. The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathol. Biol. (Paris) 48: 190-202, 2000
16 Maga, G., Hubscher, U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 116(Pt15): 3051-3060, 2003   DOI   ScienceOn
17 Harper, J.W. Cyclin dependent kinase inhibitors. Cencer Surv. 29: 91-107, 1997
18 Li, Y., Jenkins, C.W., Nichols, M.A., Xiong, Y. Cell cycle expression and p53 regulation of the cyclin- dependent kinase inhibitor p21. Oncogene 9: 2261-2268, 1994
19 Hussain, S.P., Harris, C.C. Molecular epidemiology of human cancer. Recent Results Cancer Res. 154: 22-36, 1998
20 He, X.S., Chen, H.S., Chu, K., Rivkina, M., Robinson, W.S. Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen. Proc Natl Acad Sci U S A. 93: 7274-7278, 1996
21 Sherr, C.J. The Pezcoller lecture: cancer cell cyclesrevisited. Cancer Res. 60: 3689-3695, 2000
22 焦樹德. 方劑心得十講. 北京, 人民衛生出版社, pp 5-7, 2005
23 Jiang, H., Lin, J., Su, Z.Z., Collart, F.R., Huberman, E., Fisher, P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53, Oncogene 9: 3397-3406, 1994